Bionano Genomics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $17.4M | $10.1M | $1.0M |
| FY2018 | $14.7M | $24.8M | $16.5M |
| FY2019 | $26.6M | $30.2M | $17.3M |
| FY2020 | $25.4M | $60.5M | $38.4M |
| FY2021 | $40.0M | $377.1M | $24.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $17.4M | $10.1M | $1.0M |
| FY2018 | $14.7M | $24.8M | $16.5M |
| FY2019 | $26.6M | $30.2M | $17.3M |
| FY2020 | $25.4M | $60.5M | $38.4M |
| FY2021 | $40.0M | $377.1M | $24.6M |